FdaApplication

NDA 201811

Back to search

Identifiers

Properties

PropertyValue
applicant_nameFRESENIUS KABI USA LLC
application_typeNDA
approval_date2015-03-23

Products (1)

ProductActive ingredientStrengthDosage form
ARGATROBANARGATROBAN250MG/2.5ML (100MG/ML)INJECTABLE;INJECTION

1 product